Tests on eight Tunisian players came back positive for the banned substance clenbuterol, a drug that is commonly used to promote fat loss and muscle growth, according to the British newspaper Daily ...

Muscle loss is a well-publicized side effect of GLP-1 drugs, prompting a surge of interest in ingredients that can attenuate ...

Doctors weigh in on how peptides are impacting gay men's body image and whether these drugs are hazardous to their health.

While protein plus resistance training (weight-lifting or bodyweight exercises) is the most studied way to build muscle, research shows that the following nutrients may also boost your muscle gains. 1 ...

A workout that requires little to no equipment helps build a foundation in muscle stamina, endurance, grip strength and ...

It takes just a few seconds, but experts say your grip strength could offer important clues about healthy aging, muscle ...

On the never-ending quest to build a bigger chest, pushups remain a go-to bodyweight move, and they've stood the test of time ...

Before testing new therapies in animals, researchers now have a more efficient starting point—lab-grown canine muscle cells that can help identify what works and what doesn't. Developed at the Texas A ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Trial suggests monoclonal antibody can help retain lean body mass when losing weight with GLP-1 medicines A drug that promotes muscle growth could significantly reduce the loss of lean body mass when ...

The GDP growth data released on Friday simultaneously portray recent economic strength and reveal some reasons for worry. The provisional estimates of GDP growth for 2025-26 have been pegged at 7.7%, ...

Xintec, TSMC's packaging and testing unit, is preparing for a broader testing-led expansion that could affect global chip supply chains. The company said capacity gains, new equipment spending, and ...